We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 101-120 of 967 results
  1. Epithelial–Mesenchymal Transition and Cancer Stem Cells

    Epithelial–mesenchymal transition (EMT), a cellular phenotypic change from epithelial to mesenchymal-like features, is related to the resistance and...
    Chapter 2022
  2. Novel sequential treatment with palbociclib enhances the effect of cisplatin in RB-proficient triple-negative breast cancer

    Background

    Triple-negative breast cancer (TNBC) is a highly aggressive malignancy that lacks sensitivity to chemotherapy, endocrine therapy or...

    Ya**g Huang, Hao Wu, **ngrui Li in Cancer Cell International
    Article Open access 12 October 2020
  3. Hedyotis diffusae Herba-Andrographis Herba inhibits the cellular proliferation of nasopharyngeal carcinoma and triggers DNA damage through activation of p53 and p21

    Dysregulation of the cell cycle and the resulting aberrant cellular proliferation has been highlighted as a hallmark of cancer. Certain traditional...

    Zhiqing Liu, Shan Mu, ... Hui **e in Cancer Gene Therapy
    Article 09 November 2021
  4. Proteolysis-targeting chimeras (PROTACs) in cancer therapy

    Proteolysis-targeting chimeras (PROTACs) are engineered techniques for targeted protein degradation. A bifunctional PROTAC molecule with two...

    **nyi Li, Wenchen Pu, ... Yong Peng in Molecular Cancer
    Article Open access 11 April 2022
  5. Pulmonary Arterial Hypertension

    Mario Boehm, Ralph T. Schermuly in Encyclopedia of Molecular Pharmacology
    Living reference work entry 2021
  6. Pulmonary Arterial Hypertension

    Mario Boehm, Ralph T. Schermuly in Encyclopedia of Molecular Pharmacology
    Reference work entry 2021
  7. The Intricacy of ROS in Cancer Therapy Resistance

    Cancer is one of the notable causes of death universally due to the emergence of therapy resistance despite the evolution of encouraging therapeutic...
    Chandan Kanta Das, Ranabir Majumder, ... Mahitosh Mandal in Handbook of Oxidative Stress in Cancer: Mechanistic Aspects
    Reference work entry 2022
  8. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer

    Breast cancer is the second leading cause of death for women worldwide. The heterogeneity of this disease presents a big challenge in its therapeutic...

    Feng Ye, Saikat Dewanjee, ... Hailin Tang in Molecular Cancer
    Article Open access 06 July 2023
  9. Human papillomavirus-mediated carcinogenesis and tumor progression

    High-risk human papillomaviruses (HPV) cause 5% of all human cancers and are primary etiologic agents of cervical, anal, and oropharyngeal cancer....

    Fadi Abboodi, Nella C. Delva, ... Lucia Pirisi in Genome Instability & Disease
    Article 15 April 2021
  10. Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance

    Chemotherapy, radiotherapy, targeted therapy, and immunotherapy are established cancer treatment modalities that are widely used due to their...

    Ting-Wan Kao, Geng-Hao Bai, ... Yao-An Shen in Journal of Experimental & Clinical Cancer Research
    Article Open access 18 July 2023
  11. Protein post-translational modifications in the regulation of cancer hallmarks

    Posttranslational modifications (PTMs) of proteins, the major mechanism of protein function regulation, play important roles in regulating a variety...

    Haiying Wang, Liqian Yang, ... Jianyuan Luo in Cancer Gene Therapy
    Article 07 April 2022
  12. The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer

    Background

    The cyclin D1-cyclin dependent kinases (CDK)4/6 inhibitor palbociclib in combination with endocrine therapy shows remarkable efficacy in...

    Marianna Talia, Francesca Cirillo, ... Rosamaria Lappano in Journal of Experimental & Clinical Cancer Research
    Article Open access 18 June 2024
  13. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis

    Background

    Altered glucose metabolism endows tumor cells with metabolic flexibility for biosynthesis requirements. Phosphoenolpyruvate carboxykinase 1...

    Lin Tuo, ** **ang, ... Ni Tang in Journal of Experimental & Clinical Cancer Research
    Article Open access 04 February 2019
  14. Transcriptional Control Leading to Clinical Outcomes in Breast Cancer Cases

    Transcription is an important event that use information from a gene and make its protein. Specific transcription factors are involved in the process...
    Ayesha Aftab, Ranjha Khan, ... Bashir Ahmad in Breast Cancer: From Bench to Personalized Medicine
    Chapter 2022
  15. Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis

    Prostate cancer (PCa) is a commonly diagnosed malignancy in men. The transcription factor p53, a well-known cancer suppressor, has been extensively...

    Dong Zhang, **ao-Jie Yang, ... Tie Chong in Cancer Gene Therapy
    Article 19 November 2021
  16. Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?

    Cyclin-dependent kinases (CDK) control the cell cycle and play a crucial role in oncogenesis. Pharmacologic inhibition of CDK has contributed to the...

    Christin Riess, Nina Irmscher, ... Claudia Maletzki in Cancer and Metastasis Reviews
    Article Open access 08 November 2020
  17. Dynamical Methods to Study Interaction in Proteins Facilitating Molecular Understanding of Cancer

    Protein-protein interactions coordinate functions within a cell making it fit to survive. Some of the proteins in this network of interactions act as...
    Bhaskar Dasgupta, Gert-Jan Bekker, Narutoshi Kamiya in Handbook of Oxidative Stress in Cancer: Mechanistic Aspects
    Living reference work entry 2021
  18. Targeting transcription cycles in cancer

    Accurate control of gene expression is essential for normal development and dysregulation of transcription underpins cancer onset and progression....

    Stephin J. Vervoort, Jennifer R. Devlin, ... Ricky W. Johnstone in Nature Reviews Cancer
    Article 21 October 2021
  19. Role of microRNA-34b-5p in cancer and injury: how does it work?

    MicroRNAs (miRNAs or miRs) are a class of noncoding single-stranded RNAs that can regulate gene expression by binding to the untranslated sequences...

    Xuechun Bai, Lianwen Zheng, ... Dandan Li in Cancer Cell International
    Article Open access 01 December 2022
  20. The circular RNA circZFR phosphorylates Rb promoting cervical cancer progression by regulating the SSBP1/CDK2/cyclin E1 complex

    Background

    As a novel type of non-coding RNA, circular RNAs (circRNAs) play a critical role in the initiation and development of various diseases,...

    Mingyi Zhou, Zhuo Yang, ... Yong Zhang in Journal of Experimental & Clinical Cancer Research
    Article Open access 30 January 2021
Did you find what you were looking for? Share feedback.